Related Experiment Video
Updated: Jun 26, 2025
Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
Published on: March 21, 2021
Sarcopenia in gynaecological cancers
Riccardo Di Fiore1, Rosa Drago-Ferrante2, Sherif Suleiman3
1Department of Anatomy, Faculty of Medicine and Surgery, University of Malta, MSD 2080, Msida, Malta; Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, 19122, USA.
Sarcopenia, the loss of muscle mass and function, is increasingly recognized as a significant indicator of poor prognosis in gynecological cancers (GCs). Understanding its clinical importance is crucial for improving patient outcomes in these diseases.
Area of Science:
- Oncology
- Geriatrics
- Pathophysiology
Background:
- Gynecological cancers (GCs) present significant global mortality challenges, often due to late detection.
- Sarcopenia, characterized by systemic skeletal muscle mass and function loss, is a multifactorial condition linked to aging, malnutrition, and chronic diseases, including cancer.
- Cancer cachexia, driven by anorexia and inflammation, accelerates muscle catabolism, positioning sarcopenia as a marker for poor health and advanced malignancy.
Purpose of the Study:
- To review the clinical significance of sarcopenia in patients diagnosed with gynecological cancers.
- To highlight the prognostic value of sarcopenia within the context of various gynecological malignancies.
Main Methods:
- Literature review of existing studies on sarcopenia and gynecological cancers.
- Synthesis of evidence regarding the relationship between muscle mass, function, and outcomes in gynecological cancer patients.
Main Results:
- Growing evidence indicates sarcopenia is a significant prognostic factor across multiple cancer types, including gynecological cancers.
- Sarcopenia serves as an indicator of overall health status and potentially advanced disease in cancer patients.
Conclusions:
- Sarcopenia holds considerable clinical importance for patients with gynecological cancers.
- Further research and multidisciplinary efforts are needed to leverage sarcopenia for improved diagnostic, prognostic, and therapeutic strategies in GCs.
Related Concept Videos
01:29Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:24Disorders of the Female Reproductive System
01:03Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...